Garrod E, Robinson K, McCrae K, Nicholson M, Choi JC, Socías ME, Fairbairn N Feasibility and acceptability of a pilot contingency management intervention for stimulant use disorder in a hospital setting J Addict Med PubMed

Zhou VY, Fairbairn N, Lei J, Brar R, Bach P, Socías ME Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: a population-based target trial emulation Addiction PubMed

Lyman K, Choi JC, Jutras-Aswad D, Le Foll B, Klaire S, Socías ME Differential impacts of methadone and buprenorphine/naloxone on pain-related outcomes among people with non-heroin opioid use disorder: secondary analyses from a pragmatic Canadian multisite trial Drug Alcohol Rev PubMed

McAdam E, Reddon H, Socías ME, Lake S, Hayashi K, DeBeck K, Walsh Z, Milloy MJ Self-reported cannabis use to manage opioid withdrawal symptoms and reductions in opioid use among people who use unregulated opioids: a cross-sectional analysis J Cannabis Res PubMed

Socías ME, Lei J, Zhou V, Anand R, Cui Z, Penta S, Larochelle MR, Lodi S, Fairbairn N Slow-release oral morphine vs methadone for opioid use disorder in the fentanyl era JAMA Netw Open PubMed

Mihic T, Socías ME, McCrae K, Johnson C, Nolan S, Grant C, Sutherland C, Fairbairn N Community pharmacy-based injectable opioid agonist treatment: findings from a Canadian pilot program Drug Alcohol Rev PubMed

Socías ME, Dickhout P, Langlois J, Grant C, Nolan S Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: the FASTER-BUP udy [sic] Drug Alcohol Depend PubMed

Jackson E, Bach P, Socías ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis B Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: findings from a prospective cohort study from 2013 to 2020 Drug Alcohol Depend PubMed

Crepeault H, Cowan N, Socías ME, Riazi N, Knill A, Khela A, Wood E, Ti L Applying a modified version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian community withdrawal management setting Drug Alcohol Rev PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J PubMed